Showing results (371-380 of 451) with videos related to

Sort By:
Pageof 46
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 25, 2023
Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-upCheng-Long Huang, Gao-Yuan Wang, Jia-Hao Lou, et al.
Cancer Medicine|March 31, 2022
The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinomaXiao-Min Li, Xiao-Min Zhang, Jun-Yan Li, et al.
Oral Oncology|March 9, 2019
Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrualYa-Qin Wang, Jia-Wei Lv, Ling-Long Tang, et al.
The Journal of Biological Chemistry|April 7, 2023
VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent mannerZi-Qi Zheng, Zhuo-Hui Huang, Ye-Lin Liang, et al.
Oncotarget|September 4, 2015
Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysisYu-Pei Chen, Wen-Na Zhang, Lei Chen, et al.
Neurosurgical Review|January 12, 2022
Deep brain stimulation for chorea-acanthocytosis: a systematic reviewYang Wu, Yang-Yang Xu, Yuan Gao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal CarcinomaQing-Jie Li, Xue-Liang Fang, Ying-Qin Li, et al.
Neurosurgical Review|August 14, 2023
Spinal cord stimulation and deep brain stimulation for disorders of consciousness: a systematic review and individual patient data analysis of 608 casesYang Wu, Yang-Yang Xu, Hao Deng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
[A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma]Yan-Ping Mao, Wen-Fei Li, Lei Chen, et al.
Frontiers in Pharmacology|July 23, 2025
Dihydroartemisinin targets the miR-497-5p/SOX5 axis to suppress tumor progression in non-small cell lung cancerQing-Hua Yin, Qiang Zhou, Jian-Bing Hu, et al.
Pageof 46